These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening. Marathe PH, Lee JS, Greene DS, Barbhaiya RH. Br J Clin Pharmacol; 1996 Jan; 41(1):21-7. PubMed ID: 8824689 [Abstract] [Full Text] [Related]
5. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol. Barbhaiya RH, Shukla UA, Greene DS, Breul HP, Midha KK. J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415 [Abstract] [Full Text] [Related]
6. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers. Dockens RC, Greene DS, Barbhaiya RH. J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392 [Abstract] [Full Text] [Related]
7. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam. Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH. J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428 [Abstract] [Full Text] [Related]
11. A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses. Barbhaiya RH, Buch AB, Greene DS. J Clin Psychopharmacol; 1996 Feb; 16(1):19-25. PubMed ID: 8834414 [Abstract] [Full Text] [Related]